dacarbazine has been researched along with Acute Lymphoid Leukemia in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (18.75) | 18.2507 |
| 2000's | 5 (31.25) | 29.6817 |
| 2010's | 8 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Champlin, R; Cortes, J; Estrov, Z; Garcia-Manero, G; Garris, R; Huang, X; Jabbour, E; Jacob, J; Jain, N; Kadia, T; Kantarjian, H; Kebriaei, P; Khouri, MR; Konopleva, M; Marin, D; O'Brien, S; Patel, Y; Ravandi, F; Rytting, M; Sasaki, K; Short, NJ; Takahashi, K; Thomas, D | 1 |
| Frey, N; Goldstein, S; Hexner, EO; Landsburg, DJ; Loren, A; Luger, S; Nasta, SD; Perl, AE; Porter, DL; Stadtmauer, E; Tsai, DE | 1 |
| Askaa, J; Baggerly, KA; Coombes, KR; Knudsen, S; Mazin, W; Wang, W | 1 |
| Chang, PY; Chou, KN; Lin, YC; Liu, MY | 1 |
| Ahmed, N; Katragadda, S; Ponce, D; Rasul, M; Seiter, K | 1 |
| Hosono, A; Makimoto, A; Miyakita, Y; Momota, H; Nariata, Y; Narita, Y; Shibui, S | 1 |
| Ichikawa, M; Kurokawa, M; Nakamura, F; Nannya, Y; Ogura, M; Tanaka, M; Todo, T | 1 |
| Hotta, T; Shimoyama, M; Tobinai, K; Tsukasaki, K | 1 |
| Auman, JT; Brown, CC; Havener, TM; Krauss, RM; Mangravite, LM; McLeod, HL; Medina, MW; Motsinger-Reif, AA | 1 |
| Ahmed, T; Baskind, P; Liu, D; Loughran, T; Seiter, K; Siddiqui, A | 1 |
| Baruchel, S; Becker, L; Bouffet, E; Gammon, J; Hargrave, D; Rutka, J | 1 |
| Ogawa, M; Ueda, T; Yamauchi, T | 1 |
| Cooper, DL; Levy, A; Salloum, E; Tallini, G | 1 |
| Andrieu, JM; Colonna, P; Delwail, V; Jais, JP | 1 |
| Kiss, A; Rák, K; Telek, B; Ujj, G | 1 |
| Deans, B; Tisdale, MJ | 1 |
3 review(s) available for dacarbazine and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
Temozolomide may induce therapy-related acute lymphoblastic leukaemia.
Topics: Antineoplastic Agents, Alkylating; Dacarbazine; Glioma; Humans; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Temozolomide | 2011 |
Lymphoma study group of JCOG.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Approval; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Japan; Kaplan-Meier Estimate; Lymphoma; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Molecular Targeted Therapy; Multiple Myeloma; Neoplasm Staging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Randomized Controlled Trials as Topic; Vincristine | 2012 |
Burkitt's lymphoma-leukemia in patients treated for Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Burkitt Lymphoma; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Follicular; Mechlorethamine; Mediastinal Neoplasms; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Procarbazine; Spinal Neoplasms; Thoracic Vertebrae; Vinblastine; Vincristine | 1996 |
4 trial(s) available for dacarbazine and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
Salvage Chemoimmunotherapy With Inotuzumab Ozogamicin Combined With Mini-Hyper-CVD for Patients With Relapsed or Refractory Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia: A Phase 2 Clinical Trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dacarbazine; Dexamethasone; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Female; Hematopoietic Stem Cell Transplantation; Humans; Inotuzumab Ozogamicin; Male; Middle Aged; Philadelphia Chromosome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Salvage Therapy; Survival Analysis; Vincristine; Young Adult | 2018 |
Receipt of maintenance therapy is most predictive of survival in older acute lymphoblastic leukemia patients treated with intensive induction chemotherapy regimens.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Cisplatin; Cyclophosphamide; Dacarbazine; Dexamethasone; Disease-Free Survival; Doxorubicin; Female; Humans; Incidence; Infections; Male; Middle Aged; Philadelphia Chromosome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Predictive Value of Tests; Remission Induction; Retrospective Studies; Risk Factors; Survival Rate; Vincristine; Vindesine | 2013 |
Temozolomide and cisplatin in relapsed/refractory acute leukemia.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Drug Resistance, Neoplasm; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Salvage Therapy; Temozolomide; Treatment Failure; Young Adult | 2009 |
Phase I study of temozolomide in relapsed/refractory acute leukemia.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Dacarbazine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Temozolomide; Treatment Outcome | 2002 |
9 other study(ies) available for dacarbazine and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
Independent validation of a model using cell line chemosensitivity to predict response to therapy.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Bleomycin; Breast Neoplasms; Cell Line, Tumor; Dacarbazine; Doxorubicin; Epirubicin; Female; Gene Expression Regulation, Neoplastic; Hodgkin Disease; Humans; Linear Models; Logistic Models; Male; Middle Aged; Multivariate Analysis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Predictive Value of Tests; ROC Curve; Treatment Outcome; Vinblastine | 2013 |
Temozolomide-related acute lymphoblastic leukemia with translocation (4;11)(q21;q23) in a glioblastoma patient.
Topics: Antineoplastic Agents, Alkylating; Bone Marrow; Brain Neoplasms; Cytogenetic Analysis; Dacarbazine; Fatal Outcome; Female; Glioblastoma; Humans; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Temozolomide; Translocation, Genetic | 2014 |
Acute lymphoblastic leukemia after temozolomide treatment for anaplastic astrocytoma in a child with a germline TP53 mutation.
Topics: Antineoplastic Agents, Alkylating; Astrocytoma; Brain Neoplasms; Child; Dacarbazine; Female; Frontal Lobe; Genes, p53; Germ-Line Mutation; Humans; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Temozolomide | 2010 |
A genome-wide association analysis of temozolomide response using lymphoblastoid cell lines shows a clinically relevant association with MGMT.
Topics: Antineoplastic Agents, Alkylating; Cell Line, Tumor; Dacarbazine; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Gene Expression Regulation, Neoplastic; Genome-Wide Association Study; Genome, Human; Humans; Polymorphism, Single Nucleotide; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Temozolomide; Tumor Suppressor Proteins | 2012 |
Response to low dose temozolomide in radiation induced gliomatosis cerebri.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; Female; Humans; Leukemia, B-Cell; Magnetic Resonance Imaging; Neoplasms, Neuroepithelial; Neoplasms, Radiation-Induced; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Temozolomide; Treatment Outcome | 2003 |
Carmustine-resistant cancer cells are sensitized to temozolomide as a result of enhanced mismatch repair during the development of carmustine resistance.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cadmium Chloride; Carmustine; Cell Line, Tumor; Cell Proliferation; Comet Assay; Dacarbazine; DNA Mismatch Repair; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Guanine; Humans; Hydroxylamines; Nimustine; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Temozolomide | 2008 |
Fifteen-year secondary leukaemia risk observed in 761 patients with Hodgkin's disease prospectively treated by MOPP or ABVD chemotherapy plus high-dose irradiation.
Topics: Actuarial Analysis; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Leukemia; Leukemia, Myeloid, Acute; Male; Mechlorethamine; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Procarbazine; Prospective Studies; Radiotherapy Dosage; Radiotherapy, Adjuvant; Risk; Vinblastine; Vincristine | 2002 |
[Secondary acute leukemia in Hodgkin's disease].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Vinblastine; Vincristine | 1992 |
Antitumour imidazotetrazines XXVIII 3-methyladenine DNA glycosylase activity in cell lines sensitive and resistant to temozolomide.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Burkitt Lymphoma; Cell Line; Cell Survival; Chromatography, High Pressure Liquid; Colonic Neoplasms; Dacarbazine; DNA Glycosylases; DNA Repair; DNA, Neoplasm; Drug Resistance; Humans; Kinetics; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lung Neoplasms; Mice; N-Glycosyl Hydrolases; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sulfuric Acid Esters; Temozolomide | 1992 |